Circulating modified metabolites and a risk of ESRD in patients with type 1 diabetes and chronic kidney disease

Diabetes Care

Volumn 40, Issue 3, 2017, Pages 383-390

  Niewczas, Monika A ^a,b   Mathew, Anna V ^c   Croall, Stephanie ^a   Byun, Jaeman ^c   Major, Melissa ^a   Sabisetti, Venkatta S ^d   Smiles, Adam ^a   Bonventre, Joseph V ^b,d   Pennathur, Subramaniam ^c   Krolewski, Andrzej S ^a,b  

^a JOSLIN DIABETES CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C GLYCOSYLTRYPTOPHAN; CREATININE; DRUG METABOLITE; N ACETYLSERINE; N ACETYLTHREONINE; N6 ACETYLLYSINE; N6 CARBAMOYLTHREONYLADENOSINE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; O SULFOTYROSINE; PSEUDOURIDINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DISEASE COURSE; DISEASE MARKER; END STAGE RENAL DISEASE; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLOMICS; MICROALBUMINURIA; PROSPECTIVE STUDY; PROTEINURIA; RENAL CLEARANCE; RISK ASSESSMENT; URINARY EXCRETION; URINE LEVEL; BLOOD; COMPLICATION; DIABETIC NEPHROPATHIES; FOLLOW UP; GLOMERULUS FILTRATION RATE; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TEST; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; YOUNG ADULT;

ADULT; CREATININE; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; METABOLOMICS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROTEINURIA; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; YOUNG ADULT;

EID: 85019655596     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc16-0173     Document Type: Article

References (38)

1. Krolewski AS. Progressive renal decline: The new paradigm of diabetic nephropathy in type 1 diabetes. Diabetes Care 2015;38:954-962
2. Skupien J, Warram JH, Smiles AM, et al. The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease. Kidney Int 2012;82: 589-597
3. Niewczas MA, Sirich TL, Mathew AV, et al. Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study. Kidney Int 2014;85:1214-1224
4. Merchant ML, Perkins BA, Boratyn GM, et al. Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria. J Am Soc Nephrol 2009;20:2065-2074
5. PezzolesiMG, Satake E, McDonnell KP, Major M, Smiles AM, Krolewski AS. Circulating TGF-b1-regulated miRNAs and the risk of rapid progression to ESRD in type 1 diabetes. Diabetes 2015; 64:3285-3293
6. Rhee EP, Clish CB, Ghorbani A, et al. A combined epidemiologic and metabolomic approach improves CKD prediction. J Am Soc Nephrol 2013;24:1330-1338
7. Sas KM, Karnovsky A, Michailidis G, Pennathur S. Metabolomics and diabetes: Analytical and computational approaches. Diabetes 2015;64:718-732
8. Sharma K, Karl B, Mathew AV, et al. Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. J Am Soc Nephrol 2013;24:1901-1912
9. Sekula P, Goek ON, Quaye L, et al. A metabolome-wide association study of kidney function and disease in the general population. J Am Soc Nephrol 2015;27:1175-1188
10. Rosolowsky ET, Skupien J, Smiles AM, et al. Risk for ESRD in type 1 diabetes remains high despite renoprotection. J Am Soc Nephrol 2011; 22:545-553
11. WarramJH, Gearin G, Laffel L, Krolewski AS. Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol 1996;7:930-937
12. Inker LA, Schmid CH, Tighiouart H, et al.; CKD-EPI Investigators. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012;367:20-29
13. U.S. Renal Data System. USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2013
14. Center for Disease Control and Prevention; National Center for Health Statistics. National Death Index [Internet]. Available from https://www.cdc .gov/nchs/ndi. Accessed 1 September 2013
15. Dehaven CD, Evans AM, Dai H, Lawton KA. Organization of GC/MS and LC/MS metabolomics data into chemical libraries. J Cheminform 2010;2:9
16. Ohta T, Masutomi N, Tsutsui N, et al. Untargeted metabolomic profiling as an evaluative tool of fenofibrate-induced toxicology in Fischer 344 male rats. Toxicol Pathol 2009;37:521-535
17. Looker HC, ColomboM, Hess S, et al.;SUMMIT Investigators. Biomarkers of rapid chronic kidney disease progression in type 2 diabetes. Kidney Int 2015;88:888-896
18. Gohda T, Walker WH, Wolkow P, et al. Elevated urinary excretion of immunoglobulins in nonproteinuric patients with type 1 diabetes. Am J Physiol Renal Physiol 2012;303:F157-F162
19. Sabbisetti VS, Waikar SS, Antoine DJ, et al. Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes. J Am Soc Nephrol 2014;25:2177-2186
20. Vaidya VS, Niewczas MA, Ficociello LH, et al. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-Acetyl-b-D-glucosaminidase. Kidney Int 2011;79:464-470
21. Pencina MJ, DAgostino RB Sr, DAgostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-172; discussion 207-212
22. Duranton F, Cohen G, De Smet R, et al.; European Uremic Toxin Work Group. Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol 2012;23:1258-1270
23. Rhee EP, Souza A, Farrell L, et al. Metabolite profiling identifies markers of uremia. J Am Soc Nephrol 2010;21:1041-1051
24. Tanaka H, Sirich TL, Plummer NS, Weaver DS, Meyer TW. An enlarged profile of uremic solutes. PLoS One 2015;10:e0135657
25. Ihara Y, Manabe S, KandaM, et al. Increased expression of protein C-mannosylation in the aortic vessels of diabetic Zucker rats. Glycobiology 2005;15:383-392
26. Kanan Y, Brobst D, Han Z, Naash MI, Al-Ubaidi MR. Fibulin 2, a tyrosine O-sulfated protein, is up-regulated following retinal detachment. J Biol Chem 2014;289:13419-13433
27. Kosanam H, Thai K, Zhang Y, et al. Diabetes induces lysine acetylation of intermediary metabolism enzymes in the kidney. Diabetes 2014; 63:2432-2439
28. Kalim S, Karumanchi SA, Thadhani RI, Berg AH. Protein carbamylation in kidney disease: pathogenesis and clinical implications. Am J Kidney Dis 2014;64:793-803
29. Hille A, Rosa P, Huttner WB. Tyrosine sulfation: A post-Translational modification of proteins destined for secretion? FEBS Lett 1984; 177:129-134
30. Moore KL. The biology and enzymology of protein tyrosine O-sulfation. J Biol Chem 2003; 278:24243-24246
31. Furmanek A, Hofsteenge J. Protein C-mannosylation: facts and questions. Acta Biochim Pol 2000;47:781-789
32. Charette M, Gray MW. Pseudouridine in RNA: what, where, how, and why. IUBMB Life 2000;49:341-351
33. Chow CS, Lamichhane TN, Mahto SK. Expanding the nucleotide repertoire of the ribosome with post-Transcriptional modifications. ACS Chem Biol 2007;2:610-619
34. Liu R, Zhong Y, Li X, et al. Role of transcription factor acetylation in diabetic kidney disease. Diabetes 2014;63:2440-2453
35. Zhao S, Xu W, Jiang W, et al. Regulation of cellular metabolism by protein lysine acetylation. Science 2010;327:1000-1004
36. Wang Z, Nicholls SJ, Rodriguez ER, et al. Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med 2007;13: 1176-1184
37. FarzanM, Mirzabekov T, Kolchinsky P, et al. Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell 1999;96:667-676
38. KatoM, Natarajan R. Diabetic nephropathyd emerging epigenetic mechanisms. Nat Rev Nephrol 2014;10:517-530